Scripps 36th Annual New Treatments in Chronic Liver Disease 2022

Scripps 36th Annual New Treatments in Chronic Liver Disease 2022

Regular price
$20.00
Sale price
$20.00
Regular price
Sold out
Unit price
per 

Scripps 36th Annual New Treatments in Chronic Liver Disease 2022

Format: 17 videos + 1 pdf, size: 4.81 GB

Course Audience: hepatologists, gastroenterologists, infectious disease physican

Overview:

Course Overview

This conference will review the latest medications and therapies in liver treatment and transplantation. The results of trials and real world data using oral drugs to treat chronic viral hepatitis B and C, non-alcoholic fatty liver diseases, primary biliary cirrhosis, primary sclerosing cholangitis, hepatocellular carcinoma and complications of end-stage liver disease including thrombocytopenia will be reviewed in detail. New Treatments in Chronic Liver Disease is a comprehensive yet concise program for updating physicians on these and other commonly encountered problems in the treatment of liver diseases.

Educational Objectives

After attending this live activity, participants should be able to:

• Assess AASLD guidelines on viral hepatitis, autoimmune hepatitis and reproductive health, and chronic liver disease.

• Review vascular disorders and coagulation management principles for patients with chronic liver disease.

• Summarize guidelines on NAFLD (AGA), DILI and hemochromatosis (ACG) and non-invasive markers of fibrosis (EASL).

• Evaluate drugs in development for PBC and PSC.

• Employ strategies for treating and managing ascites and hepatorenal syndrome.

• Describe advances in HCC therapy and management of acute-on-chronic liver disease.

Target Audience

• Hepatologists

• Gastroenterologists

• Infectious Disease Specialists

 

 

brochure_liver22_compressed_v3 (PDF Format)

ACG Guidelines for DILI and Hemochromatosis – Kris Kowdley, MD (Video MP4 Format)

Acute-on-Chronic Liver Disease – Timothy Morgan, MD (Video MP4 Format)

Advanced Endoscopy in Liver Disease Patients – Matthew Skinner, MD (Video MP4 Format)

Advances in HCC – Catherine Frenette, MD (Video MP4 Format)

AGA Guidelines for NAFLD – Mazen Noureddin, MD (Video MP4 Format)

Autoimmune Hepatitis – John Vierling, MD (Video MP4 Format)

Debate- Use of Semaglutide for Obese Patients with NAFLD – Paul J. Pockros, MD, Michael Charlton, MD (Video MP4 Format)

EASL Guidelines for Non-Invasive Testing – Michael Charlton, MD (Video MP4 Format)

Panel Discussion1 (Video MP4 Format)

Panel Discussion2 (Video MP4 Format)

Panel Discussion3 (Video MP4 Format)

Reproductive Health and Chronic Liver Disease – Norah Terrault, MD (Video MP4 Format)

Update on Management of Ascites and HRS – Florence Wong, MD (Video MP4 Format)

Vascular Disorders and Anticoagulation – Patrick Northup, MD (Video MP4 Format)

Viral Hepatitis B and C – Julio Gutierrez, MD (Video MP4 Format)

When to Refer for Liver Transplantation – Adam Deising, MD (Video MP4 Format)

WILLIAM S. HAUBRICH LECTURE- What’s New in PBC and PSC- – Kris Kowdley, MD (Video MP4 Format)